These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27076675)
1. Evaluation of responses to vitamin D3 (cholecalciferol) in patients on dialysis: a systematic review and meta-analysis. Xu C; Li YC; Zhao SM; Li ZX J Investig Med; 2016 Jun; 64(5):1050-9. PubMed ID: 27076675 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
4. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial. Massart A; Debelle FD; Racapé J; Gervy C; Husson C; Dhaene M; Wissing KM; Nortier JL Am J Kidney Dis; 2014 Nov; 64(5):696-705. PubMed ID: 24856872 [TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study. Olszowiec-Chlebna M; Koniarek-Maniecka A; Brzozowska A; Błauż A; Rychlik B; Stelmach I Ital J Pediatr; 2019 Mar; 45(1):41. PubMed ID: 30922377 [TBL] [Abstract][Full Text] [Related]
7. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Delanaye P; Weekers L; Warling X; Moonen M; Smelten N; Médart L; Krzesinski JM; Cavalier E Nephrol Dial Transplant; 2013 Jul; 28(7):1779-86. PubMed ID: 23378417 [TBL] [Abstract][Full Text] [Related]
8. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Wetmore JB; Kimber C; Mahnken JD; Stubbs JR Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190 [TBL] [Abstract][Full Text] [Related]
9. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. Romagnoli E; Mascia ML; Cipriani C; Fassino V; Mazzei F; D'Erasmo E; Carnevale V; Scillitani A; Minisola S J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates. Kamr AM; Dembek KA; Reed SM; Slovis NM; Zaghawa AA; Rosol TJ; Toribio RE PLoS One; 2015; 10(6):e0127684. PubMed ID: 26046642 [TBL] [Abstract][Full Text] [Related]
12. Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Heikkinen A; Parviainen MT; Tuppurainen MT; Niskanen L; Komulainen MH; Saarikoski S Calcif Tissue Int; 1998 Jan; 62(1):26-30. PubMed ID: 9405729 [TBL] [Abstract][Full Text] [Related]
13. The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery. Smelt HJM; Pouwels S; Smulders JF Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31174403 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency. Zitt E; Sprenger-Mähr H; Mündle M; Lhotta K BMC Nephrol; 2015 Aug; 16():128. PubMed ID: 26238347 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Jean G; Souberbielle JC; Chazot C Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348 [TBL] [Abstract][Full Text] [Related]
16. [Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol]. Maganeva IS; Pigarova EA; Shulpekova NV; Dzeranova LK; Eremkina AK; Miliutina AP; Povaliaeva AA; Zhukov AY; Bogdanov VP; Rozhinskaya LY; Mokrysheva NG Probl Endokrinol (Mosk); 2021 Dec; 67(6):68-79. PubMed ID: 35018763 [TBL] [Abstract][Full Text] [Related]
17. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone. Garcia-Lopes MG; Pillar R; Kamimura MA; Rocha LA; Canziani ME; Carvalho AB; Cuppari L Ann Nutr Metab; 2012; 61(1):74-82. PubMed ID: 22889840 [TBL] [Abstract][Full Text] [Related]
18. Alterations in gene expression in vitamin D-deficiency: Down-regulation of liver Cyp7a1 and renal Oat3 in mice. Quach HP; Noh K; Hoi SY; Bruinsma A; Groothuis GMM; Li AP; Chow ECY; Pang KS Biopharm Drug Dispos; 2018 Feb; 39(2):99-115. PubMed ID: 29243851 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099 [TBL] [Abstract][Full Text] [Related]
20. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]